-PTI India however maintained that the India Patent Act was in accordance with the TRIPS Agreement & the Paris Convention The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied. "PhRMA remains concerned about the deteriorating intellectual property environment in India," Mark Grayson, PhRMA spokesman told PTI. The remarks by PhRMA or Pharmaceutical Research and Manufacturers of America, representing America's...
More »SEARCH RESULT
Age of graft -CP Chandrasekhar
-Frontline Corruption tends to be greater in periods when there is a state-engineered redistribution of wealth in favour of a few at the explicit or implicit expense of the many. Liberalisation is one such period. IT cannot be verified and may not be true. But, the view that the record of graft and corruption during the two-term, nine-year rule of the United Progressive Alliance (UPA) is the worst in India's post-Independence...
More »Frontiers without doctors-D Thamma Rao
-The Hindu The south leads in the number of medical and nursing seats, with for-profit private colleges dominating the scene. It will take major capacity expansion in the government sector to meet WHO norms on access to health professionals. India has achieved major organisational and technological successes but the health system's performance is abysmal. This cannot be attributed to poverty. It is poor health that places India 134th in the Human Development...
More »Strong medicine for poor countries-Nayanima Basu
-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...
More »The Larger Implications of the Novartis Glivec Judgment-Sudip Chaudhuri
-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...
More »